BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7585137)

  • 21. Burkholderia cepacia complex in cystic fibrosis and non-cystic fibrosis patients: identification of a cluster of epidemic lineages.
    Agodi A; Barchitta M; Gianninò V; Collura A; Pensabene T; Garlaschi ML; Pasquarella C; Luzzaro F; Sinatra F; Mahenthiralingam E; Stefani S
    J Hosp Infect; 2002 Mar; 50(3):188-95. PubMed ID: 11886194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent advances in cross-infection in cystic fibrosis: Burkholderia cepacia complex, Pseudomonas aeruginosa, MRSA and Pandoraea spp.
    Jones AM; Webb AK
    J R Soc Med; 2003; 96 Suppl 43(Suppl 43):66-72. PubMed ID: 12906328
    [No Abstract]   [Full Text] [Related]  

  • 23. Bacterial infection in cystic fibrosis (CF): special reference to mycobacteria and Burkholderia cepacia.
    Hodson ME
    Pediatr Pulmonol Suppl; 1995; 11():66-7. PubMed ID: 7547352
    [No Abstract]   [Full Text] [Related]  

  • 24. The emergence of epidemic, multiple-antibiotic-resistant Stenotrophomonas (Xanthomonas) maltophilia and Burkholderia (Pseudomonas) cepacia.
    Spencer RC
    J Hosp Infect; 1995 Jun; 30 Suppl():453-64. PubMed ID: 7560984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Bronchial mucins and infection in cystic fibrosis].
    Lamblin G; Ramphal R
    Pathol Biol (Paris); 1991 Jun; 39(6):592-7. PubMed ID: 1923590
    [No Abstract]   [Full Text] [Related]  

  • 26. Lack of MyD88 protects the immunodeficient host against fatal lung inflammation triggered by the opportunistic bacteria Burkholderia cenocepacia.
    Ventura GM; Balloy V; Ramphal R; Khun H; Huerre M; Ryffel B; Plotkowski MC; Chignard M; Si-Tahar M
    J Immunol; 2009 Jul; 183(1):670-6. PubMed ID: 19535624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The multifarious, multireplicon Burkholderia cepacia complex.
    Mahenthiralingam E; Urban TA; Goldberg JB
    Nat Rev Microbiol; 2005 Feb; 3(2):144-56. PubMed ID: 15643431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. More on the relationship between cystic fibrosis and venous thrombosis.
    Mori PG; Acquila M; Bicocchi MP; Bottini F; Romano L
    Eur J Haematol; 2000 Jul; 65(1):82-3. PubMed ID: 10914947
    [No Abstract]   [Full Text] [Related]  

  • 29. Identification and molecular epidemiology of nosocomial outbreaks due to Burkholderia cepacia in cystic fibrosis patients of Masih Daneshvary Hospital, Iran.
    Dallal MM; Telefian CF; Hajia M; Kalantar E; Dehkharghani AR; Forushani AR; Khanbabaei Q; Mobarhan M; Farzami MR
    J Prev Med Hyg; 2014 Mar; 55(1):27-30. PubMed ID: 25916029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Small Noncoding Regulatory RNAs from
    Pita T; Feliciano JR; Leitão JH
    Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30486355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cross infection between cystic fibrosis patients colonised with Burkholderia cepacia.
    Ledson MJ; Gallagher MJ; Corkill JE; Hart CA; Walshaw MJ
    Thorax; 1998 May; 53(5):432-6. PubMed ID: 9708241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Burkholderia cepacia complex: virulence characteristics, importance and relationship with cystic fibrosis.
    Coutinho HD
    Indian J Med Sci; 2007 Jul; 61(7):422-9. PubMed ID: 17611350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Healthcare-associated pneumonia - is this new entity important for diagnosis and treatment of pneumonia? contra].
    Ewig S
    Dtsch Med Wochenschr; 2010 Mar; 135(10):467. PubMed ID: 20198545
    [No Abstract]   [Full Text] [Related]  

  • 34. Epidemiology of Pseudomonas cepacia colonization among patients with cystic fibrosis.
    John M; Ecclestone E; Hunter E; Couroux P; Hussain Z
    Pediatr Pulmonol; 1994 Aug; 18(2):108-13. PubMed ID: 7526323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pseudomonas cepacia--more than a harmless commensal?
    Lancet; 1992 Jun; 339(8806):1385-6. PubMed ID: 1375968
    [No Abstract]   [Full Text] [Related]  

  • 36. [Burkholderia cepacia: a new pathogen causing nosocomial infections].
    Lipowski D; Rzadkiewicz E; Czekalska-Lachowicz E
    Przegl Epidemiol; 2008; 62(1):7-17. PubMed ID: 18536220
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Source of Pseudomonas cepacia: ribotyping of isolates from patients and from the environment.
    Fisher MC; LiPuma JJ; Dasen SE; Caputo GC; Mortensen JE; McGowan KL; Stull TL
    J Pediatr; 1993 Nov; 123(5):745-7. PubMed ID: 7693902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Burkholderia cepacia complex genomovars and pulmonary transplantation outcomes in patients with cystic fibrosis.
    De Soyza A; McDowell A; Archer L; Dark JH; Elborn SJ; Mahenthiralingam E; Gould K; Corris PA
    Lancet; 2001 Nov; 358(9295):1780-1. PubMed ID: 11734238
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lack of throat colonization with Burkholderia cepacia among cystic fibrosis healthcare workers.
    Dy ME; Nord JA; LaBombardi VJ; Germana J; Walker P
    Infect Control Hosp Epidemiol; 1999 Feb; 20(2):90. PubMed ID: 10064207
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparison by extended ribotyping of Pseudomonas cepacia isolated from cystic fibrosis patients with acute and chronic infections.
    Rozee KR; Haase D; Macdonald NE; Johnson WM
    Diagn Microbiol Infect Dis; 1994 Dec; 20(4):181-6. PubMed ID: 7535673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.